文献速递糖尿病

血压变异性与非洲加勒比族裔对1型糖尿病糖尿病肾病进展的影响

The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetes.
PubMed 文献 · Diabetologia · 2026-04-01

本研究纳入3079例1型糖尿病患者,中位年龄36岁,随访14年,评估血压变异性(BPV)与肾病进展的关系。主要终点为eGFR较基线下降≥50%且终末eGFR<30 ml/min/1.73m2,共272例(8.8%)达到终点。收缩压和舒张压的所有BPV指标均与主要终点显著相关,其中收缩压平均真实变异性(ARV)关联最强(HR 1.54,95%CI 1.27,1.87,p<0.001),非洲加勒比族裔亦为独立危险因素。

要点

  • 1型糖尿病患者收缩压和舒张压变异性均与肾病进展显著相关。
  • 收缩压平均真实变异性(ARV)关联最强,HR 1.54(95%CI 1.27,1.87,p<0.001)。
  • 非洲加勒比族裔是肾病进展的独立危险因素。

核心结论

  • 在1型糖尿病患者中,收缩压和舒张压变异性与肾病进展相关。
  • 收缩压ARV和非洲加勒比族裔是独立于传统危险因素的风险因素。

研究设计与样本

  • 回顾性队列研究,纳入3079例1型糖尿病且基线eGFR>45 ml/min/1.73m2的患者。
  • 中位年龄36岁(范围18-85),50%女性,78.5%白人,10.9%非洲加勒比裔,4.5%亚裔,6.1%其他族裔。
  • 2004至2018年间就诊于两家大学医院门诊,随访14年。
  • 采用访视校正标准差(adj-SD)、变异系数(CV)和平均真实变异性(ARV)评估收缩压和舒张压的血压变异性。
  • 主要终点为eGFR较基线下降≥50%且终末eGFR<30 ml/min/1.73m2,死亡作为竞争风险。

主要发现

  • 随访14年间,272例(8.8%)达到主要终点。
  • 收缩压和舒张压的所有BPV指标均与主要终点显著相关。
  • 多变量分析中,收缩压ARV、舒张压ARV和非洲加勒比族裔为独立风险因素。
  • 收缩压ARV关联最强:HR 1.54(95%CI 1.27,1.87,p<0.001)。

临床怎么用

  • 在1型糖尿病管理中,除平均血压外,应关注血压变异性对肾病进展的风险。
  • 非洲加勒比族裔1型糖尿病患者可能需更密切的肾病监测。

局限性

  • 需进一步研究血压变异性是否为可干预的肾病进展风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Blood pressure variability (BPV) is a risk factor for kidney disease progression in hypertension and type 2 diabetes; however, the role of BPV in kidney disease in type 1 diabetes is unknown. The aim of this study was therefore to determine whether BPV has an impact on kidney disease progression in an ethnically diverse cohort of people with type 1 diabetes. METHODS: We studied 3079 people (median age 36 [range 18-85] years; 50% female; 78.5% White, 10.9% African Caribbean, 4.5% Asian, 6.1% Other) with type 1 diabetes and baseline eGFR >45 ml/min per 1.73m2 attending two university hospital clinics between 2004 and 2018. BPV was assessed using visit-adjusted standard deviation (adj-SD), CV and average real variability (ARV) for systolic blood pressure (SBP) and diastolic blood pressure (DBP). The primary endpoint was eGFR decline of ≥50% from baseline with final eGFR <30 ml/min per 1.73m2, with death as a competing risk. RESULTS: Over a 14 year period, 272 people (8.8%) reached the primary endpoint. All BPV metrics for SBP and DBP were significantly associated with the primary endpoint. ARVs of SBP and DBP and African Caribbean ethnicity emerged as risk factors in multivariable analyses, independent of traditional risk factors, including baseline blood pressure, eGFR, HbA1c, albuminuria and mean blood pressure in the exposure window. The strongest association was observed for the ARV of SBP (HR 1.54, 95% CI 1.27, 1.87, p<0.001). CONCLUSIONS/INTERPRETATION: In people with type 1 diabetes, SBP and DBP variability are associated with kidney disease progression. Further studies are needed to investigate if BPV is a modifiable risk factor for kidney disease progression.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Ozdede M, Pavlou P, Krasniqi V, et al. The impact of blood pressure variability and African Caribbean ethnicity on the progression of diabetic kidney disease in type 1 diabetes. Diabetologia. 2026. PMID: 41922880. doi:10.1007/s00125-026-06715-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。